US 10358481
Engineered antibody constant domain molecules
granted A61PA61P29/00A61P31/16
Quick answer
US patent 10358481 (Engineered antibody constant domain molecules) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P29/00, A61P31/16, A61P31/18, A61P35/00